Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder. 2011

Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
National Center for PTSD, VA Boston Healthcare System, United States; Boston University School of Medicine, United States. mark.miller5@va.gov

This study examined the effects of oral administration of 20mg hydrocortisone on baseline and fear-potentiated startle in 63 male veterans with or without PTSD. The procedure was based on a two-session, within-subject design in which acoustic startle eyeblink responses were recorded during intervals of threat or no threat of electric shock. Results showed that the magnitude of the difference between startle responses recorded during anticipation of imminent shock compared to "safe" periods was reduced after hydrocortisone administration relative to placebo. This effect did not vary as a function of PTSD group nor were there were any significant group differences in other indices startle amplitude. Findings suggest that the acute elevations in systemic cortisol produced by hydrocortisone administration may have fear-inhibiting effects. This finding may have implications for understanding the role of hypothalamic-pituitary-adrenal (HPA)-axis function in vulnerability and resilience to traumatic stress.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001767 Blinking Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action. Orbicularis Oculi Reflex,Reflex, Blink,Reflex, Corneal,Reflex, Orbicularis Oculi,Winking,Blink Reflexes,Corneal Reflexes,Orbicularis Oculi Reflexes,Blink Reflex,Reflexes, Blink,Reflexes, Orbicularis Oculi
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000339 Affect The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves. Mood,Affects,Moods

Related Publications

Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
September 1995, Biological psychiatry,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
February 2009, Biological psychiatry,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
October 2003, Journal of traumatic stress,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
February 1999, Journal of abnormal psychology,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
October 2019, Behavioural brain research,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
April 1994, Biological psychiatry,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
March 1997, Neuroreport,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
May 2014, Journal of anxiety disorders,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
May 2001, Current protocols in neuroscience,
Mark W Miller, and Ann E McKinney, and Fredrick S Kanter, and Kristina J Korte, and William R Lovallo
August 2002, Current protocols in neuroscience,
Copied contents to your clipboard!